Tarsus Pharmaceuticals Ownership & Insider Activity

Tarsus Pharmaceuticals (TARS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.7% of shares outstanding. Institutional investors hold 48.4%. Over the past 90 days, insiders made 6 sales worth $5.2M.

Shares Outstanding

46.792M

Shares Float

45.395M

Insider Shares Owned

1.732M

Insider % Owned

3.7%

Institutional Shares Held

22.624M

Institutional % Held

48.4%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$5.2M total

Net Activity

Net Selling

Net Value (90d)

-$5.2M

Tarsus Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 15, 2026	PHD WILLIAM LINK	DIRECTOR	SELL	12.299K	$78.38	$980K
Sep 4, 2026	Bobak Azamian	PRESIDENT/CEO AND BOARD CHAIR	SELL	10.000K	$90.56	$906K
Sep 4, 2026	Yeu Elizabeth Lin	CHIEF MEDICAL OFFICER	SELL	13.953K	$87.50	$1.2M
Sep 4, 2026	Seshadri Neervannan	CHIEF OPERATING OFFICER	SELL	4.564K	$85.00	$388K
Sep 2, 2026	Bobak Azamian	PRESIDENT/CEO AND BOARD CHAIR	SELL	10.000K	$80.06	$801K
Sep 1, 2026	Yeu Elizabeth Lin	CHIEF MEDICAL OFFICER	SELL	11.578K	$77.56	$898K
Jun 17, 2026	Bobak Azamian	PRESIDENT/CEO AND BOARD CHAIR	SELL	10.000K	$61.55	$615K
Jun 15, 2026	Jeffrey Farrow	SEE REMARKS	SELL-OPTIONS	13.485K	$60.95	$877K
Jun 15, 2026	Katherine Goodrich	DIRECTOR	SELL	2.954K	$62.08	$183K
Jun 15, 2026	PHD WILLIAM LINK	DIRECTOR	SELL	12.500K	$62.12	$776K